The Colorado Center for Drug Discovery (C2D2) secured additional funding from the State of Colorado’s OEDIT Bioscience Discovery Evaluation Grant Program. C2D2 will receive $500K for 2014-2015 and an additional $250K in 2016. The funds will be used to continue assisting in the discovery and preclinical development of novel drugs created at Colorado research institutions.
The Colorado Center for Drug Discovery (C2D2) is part of a State of Colorado-sponsored initiative to promote economic development through the advancement of bioscience research. C2D2 is a unique preclinical drug discovery organization that is capable of advancing drug discovery programs through collaborative research.
"Chemical leads are discovered, drugs are invented"
In the quest to successfully discover and commercialize new drugs, two factors are paramount: validation of the biological target and creation of chemical matter that elicit the desired response. C2D2 creates the proprietary compounds for collaborators which are capable of advancing a project from genetic proof of concept to pharmacological reality. The result is that researchers are more effective at attracting federal or commercial support for their programs.
Spotlight on upcoming events: